CClinicalTrials.gg
CompletedNCT05654974ShiPUpdated Oct 22, 2024

Sexual Habits Affect Penis Size in Adulthood

An observational study in Observational Study, sponsored by University Medical Center, Kazakhstan. Completed at 1 site in Kazakhstan. Open to male participants aged 23 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-22.

Sponsored by University Medical Center, Kazakhstan · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
282
Ages
23 Years to 35 Years
Sex
Male
01

Study summary

Purpose: to assess in Kazakh adult males erect penis sizes, and study an influence of their natural physiological events and behavioral habits during their growing ages on their penile sizes nowadays.

Study Design: An observational cross-sectional survey pilot study using a correlational design with the intention-to-treat principle.

Read the detailed description

Participants. A total of 282 adult Kazakh males from the Republic of Kazakhstan and who have been visited at the urology units of three university centers in the biggest cities of the Republic of Kazakhstan (Astana, Almaty, and Karaganda) were prospectively included in the study, which took place between January 2020 and January 2021.

Measurements of the penis erect length and girth were by two doctor-urologists according to the method of Veale D et al. (2015).

Statistical analysis. Two-tailed Student's t-test, Pearson correlation and multivariate tests of the MANOVA and MANCOVA (body height as covariate) were used.

Sample size estimation. In a cross-sectional observational study in assessment of erect penis size of Kazakh adult males we supposed that the primary interest lies in assessment of erect penis sizes in the three cities (k=3). The investigators wish to be 95% sure of detecting when the mean erect penis sizes not exceed 1 mm (i.e., 1-β=0.95, and m1=1, m2=0). The standard deviation of erect penis size is likely to be 1.56 mm (i.e. SD=1.56) with a statistical power of 95% and significance level of 2.5% with the Bonferroni correction based on one-sided hypothesis testing. At the 5% Type I error rate (i.e., α=0.05), the sample size of the survey is 196.

02

Conditions studied

  • Observational Study

Keywords

  • penis size
  • frequency of erection
  • masturbation
  • coitus
  • sexual abstinence
  • body growth
03

Who can participate

Ages eligible
23 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

A total of 282 adult Kazakh males from the Republic of Kazakhstan and who have been visited at the urology units of three university centers in the biggest cities of the Republic of Kazakhstan (Astana, Almaty, and Karaganda) were prospectively included in the study, which took place between January 2020 and January 2021.

Inclusion criteria

  • male gender aged from 23 to 35 years
  • fill out the questionnaire
  • BMI ≤ 29.9 kilogram per meter square
  • a male who has at least one healthy native child
  • no non-communicable chronic diseases.

Exclusion criteria

Exclusion Criteria:

  • female gender
  • BMI ≥ 30.0 kilogram per meter square
  • infertility
  • erectile dysfunction, previous pelvic surgery, suspected hypogonadism, penile disease, or deformity
  • specific treatment with androgens
  • alcohol or drug abuse
  • history of alcohol consumption ≥ 30 g/day within the past 5 years.
04

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
282 participants (actual)
Patient registry
No

Interventions

  • Othermeasurements and questionnaire

    paper-based survey administration; erect penis length and girth measurements

05

What researchers measure

Primary outcomes

  1. erect penis length and girth

    centimeter

    Time frame: baseline

06

Study locations

1 site
  • Kuat Pernekulovich Oshakbayev
    Astana, 010000, Kazakhstan
07

References and documents

Individual participant data

Plan to share: No — we will make our data available to any investigator/reviewer on their own request, so that the personal privacy of our patients cannot be compromised

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05654974
Lead sponsor
University Medical Center, Kazakhstan
Responsible party
Kuat Oshakbayev (a principal investigator, University Medical Center, Kazakhstan) — Principal investigator
First posted
Dec 16, 2022
Start date
Dec 1, 2019
Primary completion
Nov 30, 2020
Completion
Jan 31, 2021
Last update
Oct 22, 2024

Study contacts

Bibazhar Dukenbayeva, Dr.
study director · ANADETO medical center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion